Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism

Neurologia Medico-Chirurgica

Volumn 48, Issue 7, 2008, Pages 292-297

  Mishina, Masahiro ^a   Komaba, Yuichi ^a   Kobayashi, Shiro ^a   Kominami, Shushi ^a   Fukuchi, Takaharu ^a   Mizunari, Takayuki ^a   Teramoto, Akira ^b   Katayama, Yasuo ^b  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cardiogenic embolism; Coagulation; Fibrinogenolysis; Free radical scavenger; Hemorrhagic transformation; Heparin

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; GLYCEROL; HEPARIN; NORPHENAZONE; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; BRAIN EMBOLISM; BRAIN INFARCTION; CARDIOGENIC EMBOLISM; CASE CONTROL STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; EUROPE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; RANKIN SCALE; RETROSPECTIVE STUDY; SMOKING; STROKE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIPYRINE; CEREBRAL HEMORRHAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; HEART DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS; TREATMENT OUTCOME;

EID: 48249155338     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.48.292     Document Type: Article

References (24)

1. Abe K, Yuki S, Kogure K: Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480-485, 1988
2. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34: 1056-1083, 2003
3. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41, 1993
4. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, Buck B, Ali L, Restrepo L, Vinuela F, Duckwiler G, Jahan R, Razinia T, Ovbiagele B: Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 68: 737-742, 2007
5. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R: Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32: 1330-1335, 2001
6. Cadroy Y, Dupouy D, Boneu B, Plaisancie H: Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species. J Immunol 164: 3822-3828, 2000
7. Edaravone Acute Brain Infarction Study Group: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicen-ters. Cerebrovasc Dis 15: 222-229, 2003
8. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J: Free radicals in cerebral ischemia. Stroke 9: 445-447, 1978
9. Gladstone DJ, Black SE, Hakim AM: Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33: 2123-2136, 2002
10. Gorlach A, Brandes RP, Bassus S, Kronemann N, Kirchmaier CM, Busse R, Schini-Kerth VB: Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J 14: 1518-1528, 2000
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352: 1245-1251, 1998
12. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349: 1569-1581, 1997
13. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL: Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31: 1081-1089, 2000
14. Mishina M, Komaba Y, Kobayashi S, Tanaka N, Kominami S, Fukuchi T, Mizunari T, Hamamoto M, Teramoto A, Katayama Y: Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 45: 344-348, 2005
15. Nagai N, Yamamoto S, Tsuboi T, Ihara H, Urano T, Takada Y, Terakawa S, Takada A: Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab 21: 631-634, 2001
16. Nagai N, Zhao BQ, Suzuki Y, Ihara H, Urano T, Umemura K: Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice. J Cereb Blood Flow Metab 22: 648-651, 2002
17. Okada H, Woodcock-Mitchell J, Mitchell J, Sakamoto T, Marutsuka K, Sobel BE, Fujii S: Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals. Circulation 97: 2175-2182, 1998
18. Ooneda G, Yoshida Y, Suzuki K, Shinkai H, Hori S, Kobori K, Takayama Y, Sekiguchi M: Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis, and arterial contraction. Blood Vessels 15: 148-156, 1978
19. Sakamoto T, Woodcock-Mitchell J, Marutsuka K, Mitchell JJ, Sobel BE, Fujii S: TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol 276: C1391-1397, 1999
20. Siesjo BK, Agardh CD, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1: 165-211, 1989
21. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J: Better outcome after stroke with higher serum cholesterol levels. Neurology 54: 1944-1949, 2000
22. Watanabe T, Morita I, Nishi H, Murota S: Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 33: 81-87, 1988
23. Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, Woodward M; Asia Pacific Cohort Studies Collaboration: Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 32: 563-572, 2003
24. Zhao BQ, Suzuki Y, Kondo K, Ikeda Y, Umemura K: Combination of a free radical scavenger and heparin reduces cerebral hemorrhage after heparin treatment in a rabbit middle cerebral artery occlusion model. Stroke 32: 2157-2163, 2001